These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19298388)

  • 1. Dynamics of thromboxane level changes during early phase of allograft reperfusion.
    Dołegowska B; Błogowski W; Domański L
    Clin Transplant; 2009; 23(5):716-22. PubMed ID: 19298388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it possible to predict the early post-transplant allograft function using 20-HETE measurements? A preliminary report.
    Dołegowska B; Błogowski W; Domański L
    Transpl Int; 2009 May; 22(5):546-53. PubMed ID: 19175563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adhesion molecules during kidney allograft reperfusion.
    Domański L; Gryczman M; Pawlik A; Sulikowski M; Romanowski M; Ostrowski M; Myślak M; Rózański J; Safranow K; Dutkiewicz G; Ciechanowski K
    Transpl Immunol; 2006 Nov; 16(3-4):172-5. PubMed ID: 17138050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxypurine and purine nucleoside concentrations in renal vein of allograft are potential markers of energy status of renal tissue.
    Domański L; Safranow K; Ostrowski M; Pawlik A; Olszewska M; Dutkiewicz G; Ciechanowski K
    Arch Med Res; 2007 Feb; 38(2):240-6. PubMed ID: 17227735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early phase of reperfusion of human kidney allograft does not affect an erythrocyte anti-oxidative system.
    Domański L; Dołgowska B; Safranow K; Myślak M; Rózański J; Romanowski M; Ostrowski M; Domański M; Pawlik A; Ciechanowski K
    Nephrology (Carlton); 2006 Oct; 11(5):467-70. PubMed ID: 17014563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of CuZn-superoxide dismutase, catalase and glutathione peroxidase in erythrocytes in kidney allografts during reperfusion in patients with and without delayed graft function.
    Domański L; Dołegowska B; Safranow K; Rózański J; Myślak M; Romanowski M; Sieńko J; Sulikowski T; Ostrowski M; Kedzierska K; Domański M; Chlubek D; Pawlik A; Ciechanowski K
    Clin Transplant; 2006; 20(1):67-71. PubMed ID: 16556156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival.
    Johnston O; O'kelly P; Spencer S; Donohoe J; Walshe JJ; Little DM; Hickey D; Conlon PJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2270-4. PubMed ID: 16720598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine and cytokine concentrations in the renal vein of the allograft during reperfusion.
    Domanski L; Pawlik A; Safranow K; Jakubowska K; Dziedziejko V; Chlubek D; Rozanski J; Myslak M; Romanowski M; Sulikowski T; Sienko J; Ostrowski M; Ciechanowski K
    Transplant Proc; 2007 Jun; 39(5):1319-22. PubMed ID: 17580130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function.
    Dołęgowska B; Błogowski W; Domański L
    J Am Coll Surg; 2010 Nov; 211(5):587-95. PubMed ID: 20829075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of renal functional reserve in kidney transplant recipients: a possible role of arachidonic acid metabolism alterations.
    Fagugli RM; Buoncristiani U; Selvi A; Cozzari M; Fedeli L; Bini V; Papi F; Falorni A; Palumbo R
    Clin Nephrol; 1998 Jun; 49(6):349-55. PubMed ID: 9696430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cytokine concentrations in graft renal vein during reperfusion in patients with and without delayed graft function.
    Domański L; Pawlik A; Safranow K; Rozański J; Myślak M; Sulikowski T; Romanowski M; Ostrowski M; Wiśniewska M; Domański M; Kabat-Koperska J; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):49-52. PubMed ID: 19127809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of liver allograft function by hyaluronic acid and endothelin levels.
    Suehiro T; Boros P; Emre S; Sheiner P; Guy S; Schwartz ME; Miller CM
    J Surg Res; 1997 Dec; 73(2):123-8. PubMed ID: 9441805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation.
    Schmitz V; Schaser KD; Olschewski P; Neuhaus P; Puhl G
    Eur Surg Res; 2008; 40(1):19-25. PubMed ID: 17728544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.